Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...

Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...

Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Knight Therapeutics Announces Approval of Minjuvi® (tafasitamab) in Mexico — Oct 15th, 2024

Knight Therapeutics MONTREAL, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Mexican affiliate, Grupo Biotoscana de Especialidad S.A. de C.V. has obtained regulatory appro...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) — Oct 3rd, 2024

WILMINGTON, Del., October 03, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced that today it granted an equity inducement award to Lee Heeson, the Company’s new Executive Vice President, Incyte International, pursuant to the Company’s 2024 Inducement Stock Incentive Plan. The awar...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced that it granted restricted stock unit awards (RSUs) representing an aggregate of 22,107 shares of the Company’s common stock to 26 new employees. The awards were made under the Company’s 2024 Indu...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Incyte to Report Third Quarter Financial Results — Oct 8th, 2024

WILMINGTON, Del., October 08, 2024--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its third quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 29, 2024. The schedule for the press release and conference call/webcast is ...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...

GMAB or INCY: Which Is the Better Value Stock Right Now? — Oct 8th, 2024

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Genmab A/S Sponsored ADR (GMAB) or Incyte (INCY). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. The best way...

Incyte Furthers Commitment to People Living with Atopic Dermatitis by Sharing Additional Patient Experiences as part of its Moments of Clarity Program — Oct 10th, 2024

Emily shares her eczema journey for Incyte’s Moments of Clarity program Emily on set at Moments of Clarity shoot (Photo: Business Wire) Dr. Sandra Lee on set at Moments of Clarity shoot (Photo: Business Wire) Moments of Clarity logo (Photo: Business Wire) Opzelura® (ruxolitinitb) cream ...